Mohammad A Althubiti (Mohammad Althubiti)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Chronic Rhinosinusitis

Nitric Oxide Synthase

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullatif Babakr, Mohamed Mukhtar, Mohammad A Althubiti, Hiba S Al-Amodi, Riyad Almaimani, Mohamed Mahmoud Nour Eldin, Mohamed Elzubier Elzubier, Wesam Nasif
Investigation of Hyperlipidemia Associated with Increased Levels of Oxidized Low-Density Lipoproteins and 8-Hydroxy-2´-Deoxyguanosine. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Maimonah Fuad Koshak, Mahmoud Zaki El-Readi, Mohamed Elzubier Elzubier, Bassem Refaat, Riyad Adnan Almaimani, Shakir Idris, Mohammad A Althubiti, Hiba Saeed Al-Amodi, Safaa Yehia Eid
Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats. Marine drugs 21 (11) (2023)
Abdullatif Babakr, Mohamed Mukhtar, Mohammad A Althubiti, Hiba S Al-Amodi, Riyad Almaimani, Mohamed Mahmoud Nour Eldin, Mohamed Elzubier Elzubier, Wesam Nasif
Investigation of Hyperlipidemia Associated with Increased Levels of Oxidized Low-Density Lipoproteins and 8-Hydroxy-2´-Deoxyguanosine. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Ahmed Adel Sadek, Soha Abdelwahab, Safaa Yehia Eid, Riyad A Almaimani, Mohammad A Althubiti, Mahmoud Zaki El-Readi
Overexpression of Inducible Nitric Oxide Synthase in Allergic and Nonallergic Nasal Polyp. Oxidative medicine and cellular longevity 2019 (2019)